Biosortia and Ross Youngs Announce Appointment of Jaime Streator to Board of Directors

April 07, 2026 | By Biosortia

COLUMBUS, OH, UNITED STATES, April 7, 2026 /EINPresswire.com/ — Biosortia and Founder, Ross Youngs today announced the appointment of Jaime Streator to their Board of Directors, Mr. Streator brings over four decades of deep experience in healthcare investment banking to the board, further strengthening the organizations’ strategic leadership.

“We are delighted to welcome Jaime Streator to our Board," said Ross Youngs, Chairman. “Jaime’s
extensive experience building and leading major healthcare investment banking groups, particularly his track record at Cowen, will be invaluable as we continue to advance our strategic goals. His deep understanding of the healthcare and biotechnology sectors will be a tremendous asset to Biosortia."

“I am honored to join the Biosortia team at such a pivotal moment. The company’s ability to access nature’s most elusive chemistry is a game-changer for the industry, and I look forward to leading our efforts in transforming these untapped natural secrets into the next generation of life-saving therapeutics." says Jamie Streator.